Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

NCT07529808 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Gastric Adenocarcinoma
Gastric (Stomach) Cancer
Gastroesophageal Adenocarcinoma
Gastroesophageal Cancer (GC)
Gastroesophageal Junction (GEJ) Adenocarcinoma
Gastroesophageal Junction (GEJ) Cancer
Gastrointestinal Cancer Metastatic
Gastrointestinal Adenocarcinoma
Gastrointestinal Cancers
Colorectal (Colon or Rectal) Cancer
Pancreatic Cancer
CDH17-positive Advanced Solid Tumors
Advanced Gastric Cancer

Interventions

DRUG: BHB810

Sponsor

BigHat Biosciences, Inc.